P3.18.64 Phase 1 Study to Evaluate the Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous NSCLC
Back to course
Asset Subtitle
Benjamin Besse
Meta Tag
Speaker Benjamin Besse
Topic Clinical Trials in Progress
Powered By